Centennial Bank/Ar/ Edwards Lifesciences Corp Transaction History

Centennial Bank/Ar/

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 29, 2024	BUY	$61.71 - $77.76 $4,257 - $5,365	69 Added 62.16%	180 $13.7 Million
Q4 2023 Aug 28, 2024	BUY	$61.71 - $77.76 $7,405 - $9,331	120 Added 200.0%	180 $13.7 Million
Q3 2023 Aug 28, 2024	SELL	$69.28 - $93.38 $3,533 - $4,762	-51 Reduced 45.95%	60 $4.16 Million
Q2 2023 Aug 28, 2024	SELL	$81.41 - $94.33 $8,629 - $9,998	-106 Reduced 48.85%	111 $10.5 Million
Q1 2023 Aug 28, 2024	BUY	$74.26 - $84.51 $7,871 - $8,958	106 Added 95.5%	217 $11.7 Million
Q4 2022 Aug 29, 2024	SELL	$68.3 - $87.44 $4,712 - $6,033	-69 Reduced 38.33%	111 $8.28 Million
Q4 2022 Aug 26, 2024	BUY	$68.3 - $87.44 $7,581 - $9,705	111 New	111 $8.28 Million

1,344

468M

2.56M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Centennial Bank/Ar/, based on Form 13F filings with the SEC.

Stay updated on Centennial Bank/Ar/ with notifications on news.